{ "componentChunkName": "component---src-templates-article-js", "path": "/resources/articles/dot-drug-test/", "result": {"data":{"wpArticle":{"id":"cG9zdDo1Mzk4NA==","title":"DOT Drug Test: Employer Guide to Rules, Process and Results","content":"

A DOT drug test is a urine drug test that follows the U.S. Department of Transportation’s procedures in 49 CFR Part 40. It applies to safety-sensitive transportation employees. It is collected on a federal custody form, tested by an HHS-certified laboratory for five drug classes and reviewed by a Medical Review Officer (MRO) before the employer gets a result.

\n\n

This guide is for HR and operations staff at employers with DOT-covered employees. It covers when DOT tests are required, how a test moves from collection to MRO review, what to do with each type of result, and how DOT tests differ from company drug tests. For substance-by-substance detection windows, see GoodHire’s 5-panel drug test guide. For the wider set of DOT hiring checks, see the DOT background check overview.

\n\n

What Is a DOT Drug Test?

\n

A DOT drug test is any drug test that a DOT agency rule requires. Two layers of regulation apply. Part 40 sets the procedures for every DOT test: how specimens are collected, which laboratories may test them, and how results are reviewed and reported. Each DOT agency’s own rule then sets who is covered and when testing happens, such as 49 CFR Part 382 for commercial drivers regulated by the Federal Motor Carrier Safety Administration (FMCSA).

\n

A few roles appear throughout the process:

\n\n\n

Who Must Follow DOT Drug Testing Rules?

\n

DOT testing applies to employees in safety-sensitive roles defined by these agencies:

\n\n

Coverage depends on the job duties and the agency rule, not on job title alone. DOT’s Office of Drug and Alcohol Policy and Compliance (ODAPC) offers an “Am I Covered?” decision tool. Employees who are not covered must not be tested under DOT authority, and only covered employees belong in a DOT random pool.

\n\n

What Does a DOT Drug Test Screen For?

\n

Laboratories test DOT urine specimens for five drug classes, using the cutoff levels listed in 49 CFR 40.85:

\n\n

The panel is fixed. Employers cannot add drugs to a DOT specimen or remove any from it. Semi-synthetic opioids such as oxycodone have been on the DOT panel since January 1, 2018.

\n\n

Is Fentanyl Part of the DOT Panel?

\n

Not as of September 2026. HHS added fentanyl and norfentanyl to the federal testing panels in January 2025. DOT then proposed adding them to Part 40 in September 2025. We found no final DOT rule as of this writing, so DOT tests do not yet include fentanyl. Check ODAPC for updates before relying on this.

\n\n

Can DOT Tests Use Oral Fluid?

\n

Not yet in practice. A 2023 DOT rule authorized oral fluid testing, but employers may use it only after HHS certifies at least two oral fluid laboratories. DOT’s list of certified oral fluid laboratories shows none. A DOT rule effective June 10, 2026 requires a directly observed urine collection in the limited situations where an oral fluid collection would otherwise be required. Hair testing and instant (point-of-collection) drug tests are not used for DOT drug testing.

\n\n

When Is a DOT Drug Test Required?

\n

Most DOT agencies use six test types. Exact triggers, deadlines and rates differ by agency, so the details below use FMCSA’s rules for CDL drivers as the example.

\n\n
\n\n\n\n\n\n\n\n\n\n\n\n
Test typeWhen it happensFMCSA example detail
Pre-employmentBefore the employee first performs safety-sensitive dutiesThe employer must have a verified negative result first, unless a limited exception applies (49 CFR 382.301)
RandomUnannounced selections during the yearAt least 50% of average driver positions tested for drugs in 2026; dates spread reasonably through the year (49 CFR 382.305)
Reasonable suspicionA trained supervisor observes specific signs of possible drug useSupervisors need at least 60 minutes of drug training and 60 minutes of alcohol training (49 CFR 382.603)
Post-accidentAfter an accident that meets the agency’s criteriaRequired after a fatal accident, or after an injury or tow-away accident when the driver is cited; stop trying after 32 hours and document why (49 CFR 382.303)
Return-to-dutyAfter a violation, once the SAP says the employee has complied with education or treatmentDirectly observed collection; a negative result is required before safety-sensitive work resumes
Follow-upAfter return to duty, on a schedule the SAP setsAt least six unannounced tests in the first 12 months, and possibly more for up to 48 months after that (49 CFR 40.307)
\n\n

Random rates for 2026 differ by agency. FMCSA, FTA and PHMSA set 50% for drugs, FAA sets 25%, and FRA sets 25% or 50% depending on the employee group, according to ODAPC’s random testing rates page.

\n

The FMCSA pre-employment exception is narrow. It applies only if the driver took part in a compliant DOT testing program within the previous 30 days, was tested within the past six months or was in a random pool for the previous 12 months, and no known prior employer has a record of a violation in the previous six months. The employer must also contact the prior testing program and keep the required verification.

\n\n\n
\n\n \n
\n\n \n \n \n \n\n
\n\n \n
\n\n\n
\n\n \n
\n\n \n

Get A Background Check Today

\n \n \n \n Get Started \n \n\n
\n\n \n
\n\n

How the DOT Drug Test Process Works

\n
    \n
  1. The employer directs the test. The DER or C/TPA notifies the employee. For random tests, FMCSA drivers must go to the collection site immediately after notification.
    2. \n
  2. A trained collector collects the specimen. Every DOT collection is documented on the Federal Drug Testing Custody and Control Form (CCF). The urine is split into a primary and a split specimen. Some collections must be directly observed, including all return-to-duty and follow-up tests and cases with signs of tampering (49 CFR 40.67).
    3. \n
  3. An HHS-certified laboratory tests the primary specimen. A result at or above the screening cutoff goes to a confirmation test. The laboratory reports results to the MRO, not to the employer.
    4. \n
  4. The MRO reviews the result. For a laboratory-confirmed positive, the MRO offers the employee a verification interview to present a legitimate medical explanation, such as a valid prescription. A state medical marijuana recommendation is not accepted (49 CFR 40.151).
    5. \n
  5. The employer receives a verified result. If the MRO verifies a positive result, the employee has 72 hours from notification to ask for the split specimen to be tested at a second laboratory (49 CFR 40.171).
    6. \n
\n\n

What Should an Employer Do With Each DOT Test Result?

\n

The result the MRO reports determines the employer’s next step. The table below summarizes the Part 40 rules for the most common outcomes.

\n\n
\n\n\n\n\n\n\n\n\n\n\n\n
MRO-reported resultWhat it meansEmployer’s next step
NegativeNo violationThe employee may perform safety-sensitive duties, if all other requirements are met
Negative-dilute, MRO directs recollectionVery low creatinine (2 to 5 mg/dL)Send the employee for an immediate, directly observed recollection
Negative-dilute, no MRO directionDilute, but creatinine above 5 mg/dLA retest is optional. Follow your written policy and treat all employees the same for each test type (49 CFR 40.197)
CancelledNeither positive nor negativeNo consequences. If a negative result is required (pre-employment, return-to-duty or follow-up), a new test is needed (49 CFR 40.207)
Verified positiveA DOT violationRemove the employee from safety-sensitive duties immediately, without waiting for a split specimen result, and provide a list of SAPs
Refusal to test, including adulterated or substituted specimensTreated as a violationRemove the employee from safety-sensitive duties and follow the same return-to-duty requirements as for a positive result
\n\n

After a violation, the employee cannot return to safety-sensitive work until completing the SAP process and a negative return-to-duty test. Part 40 does not require the employer to return the employee to that work; that remains a personnel decision. GoodHire’s guide to what happens when an employee fails a drug test covers broader employer considerations. FMCSA-regulated employers also have reporting duties in the FMCSA Drug and Alcohol Clearinghouse, a federal database of CDL drivers’ drug and alcohol violations. Clearinghouse queries and reporting are a separate process from administering a test.

\n\n

How Is a DOT Drug Test Different From a Non-DOT Test?

\n

Many employers run both: DOT tests for covered employees and company-policy tests for everyone else, or for testing beyond what DOT requires.

\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n
FeatureDOT drug testNon-DOT (company) drug test
Legal authorityPart 40 plus the DOT agency ruleEmployer policy, subject to state and local law
Who can be testedOnly covered safety-sensitive employeesSet by employer policy, within applicable law
SpecimenUrine (oral fluid authorized but not yet available)Urine, oral fluid, hair or other types the employer chooses, where permitted
Drug panelFixed five-class panelEmployer’s choice, such as a 4-, 5-, 8- or 10-panel test
FormFederal CCFA non-federal custody form
Laboratory and MROHHS-certified laboratory and MRO review requiredNot required by federal law; some state laws set requirements
Instant testsNot permitted for drug testsMay be allowed, depending on state law
\n\n

Part 40 keeps the two programs apart (49 CFR 40.13). The DOT test must be completed first, and a non-DOT test needs a separate urine void. A DOT specimen cannot be tested for extra drugs. A negative non-DOT result cannot be used to override a DOT result. FMCSA also expects any company-authority policy to be clearly described as the employer’s own policy, not a DOT requirement. GoodHire has separate guides to hair follicle testing and saliva testing for non-DOT programs.

\n\n

Employer Checklist for a DOT Drug Testing Program

\n

Employers may use service agents for most tasks, but under 49 CFR 40.15 the employer remains responsible for compliance. A basic program includes:

\n\n\n

Common Mistakes to Avoid

\n\n

GoodHire’s drug testing page lists DOT drug tests alongside lab-based 4-, 5-, 8- and 10-panel urine tests, with results verified by MROs. Other program elements, such as random pool management, SAP referrals and Clearinghouse obligations, remain the employer’s responsibility unless a service agent is engaged for them.

\n\n\n\n\n

Frequently Asked Questions

\n\n\n\n
\n\n \n
\n \n What drugs does a DOT drug test check for? \n\n
\n \n\n

A DOT drug test checks urine for five drug classes: marijuana, cocaine, opioids, amphetamines and phencyclidine (PCP). The opioid class includes codeine, morphine, heroin’s marker 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone and oxymorphone, and the amphetamine class includes MDMA and MDA. Employers cannot add or remove drugs from the DOT panel.

\n\n\n
\n\n
\n
\n\n\n
\n\n \n
\n \n Can a new hire start work before the DOT drug test result is back? \n\n
\n \n\n

Not in a safety-sensitive role. Under FMCSA rules, a CDL driver may not perform safety-sensitive functions until the employer receives a verified negative pre-employment result, unless a narrow exception for recently tested drivers applies. Other DOT agencies have their own pre-employment rules, so check the rule that covers your employees.

\n\n\n
\n\n
\n
\n\n\n
\n\n \n
\n \n Does a medical marijuana card or a prescription change a DOT test result? \n\n
\n \n\n

A medical marijuana recommendation does not. Part 40 prohibits the MRO from verifying a test as negative based on a physician’s recommendation for a Schedule I drug such as marijuana, regardless of state law. A valid prescription for a drug on the panel, such as oxycodone, can be a legitimate medical explanation, and the MRO decides this during the verification interview.

\n\n\n
\n\n
\n
\n\n\n
\n\n \n
\n \n What happens if an employee fails a DOT drug test? \n\n
\n \n\n

The employer must remove the employee from safety-sensitive duties as soon as the MRO reports a verified positive result and give the employee a list of substance abuse professionals. The employee cannot return to safety-sensitive work until completing the SAP’s recommendations and passing a directly observed return-to-duty test, followed by follow-up testing. Whether to return the employee to that work is the employer’s decision.

\n\n\n
\n\n
\n
\n\n\n
\n\n \n
\n \n Has DOT drug testing changed in 2025 or 2026? \n\n
\n \n\n

DOT proposed adding fentanyl and norfentanyl to its drug panel in September 2025, but no final rule had been published as of September 2026. Oral fluid testing is authorized but still unavailable because no oral fluid laboratories are HHS-certified, and a rule effective June 10, 2026 requires directly observed urine collection in the situations where oral fluid would otherwise be required. A revised federal custody form took effect April 27, 2026, and the 2023 version may be used until May 31, 2027.

\n\n\n
\n\n
\n
\n\n\n
\n\n\t\n
\n\n\t\t\t\t\t
\n\t\t\t\tDisclaimer\t\t\t
\n\t\t\n\t\t\t\t\t
\n\t\t\t\t

The resources provided here are for educational purposes only and do not constitute legal advice. We advise you to consult your own counsel if you have legal questions related to your specific practices and compliance with applicable laws.

\n\t\t\t
\n\t\t\n\t
\n\n\t\n
\n\n\n
\n\n \n
\n\n \n \n \n \n\n
\n\n \n
\n\n\n
\n\n \n
\n\n \n

Get A Background Check Today

\n \n \n \n Get Started \n \n\n
\n\n \n
","date":"2026-10-27T07:00:00","tableOfContentsGraphQL":"","author":{"node":{"firstName":"Tiffany","lastName":"Conaway","name":"Tiffany Conaway","overviewSocialMedia":{"patternsSocialMedia":[{"fieldGroupName":"User_Overviewsocialmedia_PatternsSocialMedia_LinkedinIn","patternsSocialMediaLinkedinInUrl":"https://www.linkedin.com/in/tiffanyconaway/"}]},"authorInfo":{"bio":"

Tiffany Conaway covers Checkr’s verification and drug testing offerings, along with occupational health screening, post-hire monitoring, and the candidate experience. Her work helps employers build compliant, candidate-friendly screening programs.

\n","company":null,"jobTitle":null,"companyLogo":null,"photo":{"altText":"","localFile":{"childImageSharp":{"gatsbyImageData":{"layout":"constrained","placeholder":{"fallback":"data:image/jpeg;base64,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"},"backgroundColor":"transparent","images":{"fallback":{"src":"/static/efd1a21eb6b79ec79331e4681a3a705d/76ad7/tiffany-conaway.jpg","srcSet":"/static/efd1a21eb6b79ec79331e4681a3a705d/76ad7/tiffany-conaway.jpg 512w","sizes":"(min-width: 512px) 512px, 100vw"},"sources":[{"srcSet":"/static/efd1a21eb6b79ec79331e4681a3a705d/16dee/tiffany-conaway.webp 512w","type":"image/webp","sizes":"(min-width: 512px) 512px, 100vw"}]},"width":512,"height":512}}}}}}},"featuredImage":{"node":{"altText":"Illustration of a sealed specimen cup, a custody form clipboard and a lab flask, with a truck and bus in the background.","sourceUrl":"https://live-goodhire.pantheonsite.io/wp-content/uploads/2026/09/article-dot-drug-test.png","localFile":{"publicURL":"/static/666879c4aeb2caa449ab52453e346f2e/article-dot-drug-test.png","childImageSharp":{"gatsbyImageData":{"layout":"constrained","placeholder":{"fallback":"data:image/png;base64,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"},"backgroundColor":"transparent","images":{"fallback":{"src":"/static/666879c4aeb2caa449ab52453e346f2e/f8b89/article-dot-drug-test.png","srcSet":"/static/666879c4aeb2caa449ab52453e346f2e/4953e/article-dot-drug-test.png 600w,\n/static/666879c4aeb2caa449ab52453e346f2e/dbfa1/article-dot-drug-test.png 782w,\n/static/666879c4aeb2caa449ab52453e346f2e/78737/article-dot-drug-test.png 841w,\n/static/666879c4aeb2caa449ab52453e346f2e/2e912/article-dot-drug-test.png 1081w,\n/static/666879c4aeb2caa449ab52453e346f2e/f8b89/article-dot-drug-test.png 1232w,\n/static/666879c4aeb2caa449ab52453e346f2e/0cc80/article-dot-drug-test.png 1285w,\n/static/666879c4aeb2caa449ab52453e346f2e/5673c/article-dot-drug-test.png 1476w","sizes":"(min-width: 1232px) 1232px, 100vw"},"sources":[{"srcSet":"/static/666879c4aeb2caa449ab52453e346f2e/6e1c8/article-dot-drug-test.webp 600w,\n/static/666879c4aeb2caa449ab52453e346f2e/e5329/article-dot-drug-test.webp 782w,\n/static/666879c4aeb2caa449ab52453e346f2e/dd840/article-dot-drug-test.webp 841w,\n/static/666879c4aeb2caa449ab52453e346f2e/104ab/article-dot-drug-test.webp 1081w,\n/static/666879c4aeb2caa449ab52453e346f2e/91b39/article-dot-drug-test.webp 1232w,\n/static/666879c4aeb2caa449ab52453e346f2e/f00bc/article-dot-drug-test.webp 1285w,\n/static/666879c4aeb2caa449ab52453e346f2e/47db0/article-dot-drug-test.webp 1476w","type":"image/webp","sizes":"(min-width: 1232px) 1232px, 100vw"}]},"width":1232,"height":534}}},"mediaDetails":{"height":1040,"width":2400}}},"seo":{"title":"DOT Drug Test: Employer Guide to Rules, Process and Results | GoodHire","metaDesc":"","metaRobotsNoindex":"index","metaRobotsNofollow":"follow","opengraphTitle":"DOT Drug Test: Employer Guide to Rules, Process and Results | GoodHire","opengraphDescription":"A DOT drug test is a urine test under 49 CFR Part 40. Learn when it is required, how collection and MRO review work, and how DOT and non-DOT tests differ.","opengraphPublishedTime":"","opengraphModifiedTime":"2026-09-30T17:41:44+00:00","opengraphSiteName":"GoodHire","opengraphType":"article","readingTime":11},"richSnippetSchemaJson":"","relatedArticles":{"resourcesRelatedArticles":[{"id":"cG9zdDo1MDg1MQ==","title":"5-Panel Drug Test Guide: Substances Detected & Detection Timeframes","excerpt":"

A 5-panel drug test screens for the presence of prescription and illicit drugs to help employers maintain a safe, productive workplace.

\n","slug":"5-panel-drug-test","featuredImage":{"node":{"altText":"Image of reagent strips and urine cup for urinalysis for 5-panel drug tests.","localFile":{"childImageSharp":{"gatsbyImageData":{"layout":"constrained","placeholder":{"fallback":"data:image/png;base64,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"},"backgroundColor":"transparent","images":{"fallback":{"src":"/static/578e9ada7776a29887f1e61ebd1a1454/a9625/5-Panel-Drug-Tests-Article-963x413-3-1.png","srcSet":"/static/578e9ada7776a29887f1e61ebd1a1454/36de0/5-Panel-Drug-Tests-Article-963x413-3-1.png 600w,\n/static/578e9ada7776a29887f1e61ebd1a1454/74f34/5-Panel-Drug-Tests-Article-963x413-3-1.png 782w,\n/static/578e9ada7776a29887f1e61ebd1a1454/9cf16/5-Panel-Drug-Tests-Article-963x413-3-1.png 841w,\n/static/578e9ada7776a29887f1e61ebd1a1454/a9625/5-Panel-Drug-Tests-Article-963x413-3-1.png 963w","sizes":"(min-width: 963px) 963px, 100vw"},"sources":[{"srcSet":"/static/578e9ada7776a29887f1e61ebd1a1454/0b1fc/5-Panel-Drug-Tests-Article-963x413-3-1.webp 600w,\n/static/578e9ada7776a29887f1e61ebd1a1454/9bbed/5-Panel-Drug-Tests-Article-963x413-3-1.webp 782w,\n/static/578e9ada7776a29887f1e61ebd1a1454/a94ef/5-Panel-Drug-Tests-Article-963x413-3-1.webp 841w,\n/static/578e9ada7776a29887f1e61ebd1a1454/c769f/5-Panel-Drug-Tests-Article-963x413-3-1.webp 963w","type":"image/webp","sizes":"(min-width: 963px) 963px, 100vw"}]},"width":963,"height":413}}}}}},{"id":"cG9zdDoxNTUwNQ==","title":"How To Read Drug Test Results: Understanding Negative & Positive Screening Outcomes","excerpt":"

Understanding drug test results for your candidates and employees is easy with GoodHire. Learn how to read negative and positive drug test results.

\n","slug":"how-to-read-employees-drug-test-results","featuredImage":{"node":{"altText":"Illustration of a candidate's drug test results that shows negative and positive results.","localFile":{"childImageSharp":{"gatsbyImageData":{"layout":"constrained","placeholder":{"fallback":"data:image/png;base64,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"},"backgroundColor":"transparent","images":{"fallback":{"src":"/static/53c22428240645bbf51530ba34059f53/a9625/Article-How-to-Read-Drug-Test-Results.png","srcSet":"/static/53c22428240645bbf51530ba34059f53/36de0/Article-How-to-Read-Drug-Test-Results.png 600w,\n/static/53c22428240645bbf51530ba34059f53/74f34/Article-How-to-Read-Drug-Test-Results.png 782w,\n/static/53c22428240645bbf51530ba34059f53/9cf16/Article-How-to-Read-Drug-Test-Results.png 841w,\n/static/53c22428240645bbf51530ba34059f53/a9625/Article-How-to-Read-Drug-Test-Results.png 963w","sizes":"(min-width: 963px) 963px, 100vw"},"sources":[{"srcSet":"/static/53c22428240645bbf51530ba34059f53/0b1fc/Article-How-to-Read-Drug-Test-Results.webp 600w,\n/static/53c22428240645bbf51530ba34059f53/9bbed/Article-How-to-Read-Drug-Test-Results.webp 782w,\n/static/53c22428240645bbf51530ba34059f53/a94ef/Article-How-to-Read-Drug-Test-Results.webp 841w,\n/static/53c22428240645bbf51530ba34059f53/c769f/Article-How-to-Read-Drug-Test-Results.webp 963w","type":"image/webp","sizes":"(min-width: 963px) 963px, 100vw"}]},"width":963,"height":413}}}}}},{"id":"cG9zdDo1Mzk5Ng==","title":"DOT Physical: Requirements, Exam and Employer Checklist","excerpt":"

A DOT physical is the FMCSA medical exam for commercial drivers. See what it tests, how to prepare, how long it lasts and how employers handle it.

\n","slug":"dot-physical","featuredImage":{"node":{"altText":"Illustration of a commercial truck, stethoscope, blood pressure gauge and a medical certificate with a green check seal.","localFile":{"childImageSharp":{"gatsbyImageData":{"layout":"constrained","placeholder":{"fallback":"data:image/png;base64,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"},"backgroundColor":"transparent","images":{"fallback":{"src":"/static/887dfc612bbb596f3c9a0d06f01615ab/9e3c4/article-dot-physical.png","srcSet":"/static/887dfc612bbb596f3c9a0d06f01615ab/4953e/article-dot-physical.png 600w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/dbfa1/article-dot-physical.png 782w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/78737/article-dot-physical.png 841w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/2e912/article-dot-physical.png 1081w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/0cc80/article-dot-physical.png 1285w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/5673c/article-dot-physical.png 1476w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/9e3c4/article-dot-physical.png 2400w","sizes":"(min-width: 2400px) 2400px, 100vw"},"sources":[{"srcSet":"/static/887dfc612bbb596f3c9a0d06f01615ab/6e1c8/article-dot-physical.webp 600w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/e5329/article-dot-physical.webp 782w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/dd840/article-dot-physical.webp 841w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/104ab/article-dot-physical.webp 1081w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/f00bc/article-dot-physical.webp 1285w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/47db0/article-dot-physical.webp 1476w,\n/static/887dfc612bbb596f3c9a0d06f01615ab/a895c/article-dot-physical.webp 2400w","type":"image/webp","sizes":"(min-width: 2400px) 2400px, 100vw"}]},"width":2400,"height":1040}}}}}}]}},"wp":{"overviewHubspot":{"hubspotSettings":{"vwoScriptLoading":{"vwoArticles":[{"id":"cG9zdDo4MjMx"}]}}}}},"pageContext":{"id":"cG9zdDo1Mzk4NA=="}}, "staticQueryHashes": ["164337791","1987833749","2376783257","3430361619","3827985150","3978322736","4015609409"]}